MUC1 and non-small cell lung carcinoma: The immunogenic effects of radiotherapy are thought to underlie the positive results of MUC1-targeted vaccination and, more convincingly, adjuvant PD-L1 blockade in stage III NSCLC patients treated with chemoradiation (20, 78).